Dr. Demirci is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1000 Wall St
Ann Arbor, MI 48105Phone+1 734-764-4190
Summary
- Dr. Hakan Demirci is an ocular oncologist who sees patients at the University of Michigan Kellogg Eye Center in Ann Arbor. His clinical practice focuses on the evaluation and treatment of eye cancers, including intraocular, conjunctival, adnexal, orbital, and periocular cancers in adults and children.
Dr. Demirci serves as the Director of Kellogg’s Ocular Oncology Clinic and his research interests include the translational approach to early diagnosis of eye cancers, targeted treatment of intraocular tumors, and prevention of metastasis. To make an appointment, please call Kellogg’s Ocular Oncology Clinic at 734-763-5874. To refer a patient, please visit www.kellogg.umich.edu/refer.
Education & Training
- Henry Ford Health/Henry Ford HospitalResidency, Ophthalmology, 2007 - 2010
- Graduate HospitalResidency, Internal Medicine, 2001 - 2002
- Hacettepe University FOMClass of 1993
Certifications & Licensure
- MI State Medical License 2004 - 2026
- PA State Medical License 2000 - 2008
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- 172 citationsGlobal Retinoblastoma Presentation and Analysis by National Income LevelIdo Didi Fabian, Elhassan Abdallah, Shehu U. Abdullahi, Rula A. Abdulqader, Sahadatou Adamou Boubacar
JAMA Oncology. 2020-05-01 - 71 citationsLight Emitting Diodes based Photoacoustic Imaging and Potential Clinical Applications.Yunhao Zhu, Guan Xu, Jie Yuan, Janggun Jo, Girish Gandikota
Scientific Reports. 2018-06-29 - 15 citationsFactors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma.Carol L Shields, Santosh G Honavar, Jerry A Shields, Hakan Demirci, Anna T Meadows
Archives of Ophthalmology. 2002-04-01
Journal Articles
- Change in Postoperative Opioid Prescribing Patterns for Oculoplastic and Orbital Procedures Associated with State Opioid LegislationHakan Demirci, Denise S Kim, Christine C Nelson, JAMA Ophthalmology
- Penetration of Carbon Nanotubes into the Retinoblastoma Tumor After Intravitreal Injection in LHBETATAG Transgenic Mice Reti-Noblastoma ModelHakan Demirci, MD, knepublishing.com
Authored Content
- Retinal Whitening After Lung Transplant for Cystic FibrosisJuly 2020
Press Mentions
- Dilemma for Cancer Patients as Life-Saving Meds Are Tied to Vision LossMay 18th, 2018
- Ophthalmologists Link Immunotherapy with a Serious Eye ConditionMay 7th, 2018
Professional Memberships
- Member
Other Languages
- Turkish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: